SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Parshall B Lynne – ‘4’ for 9/26/23 re: Ionis Pharmaceuticals Inc.

On:  Thursday, 9/28/23, at 6:03pm ET   ·   For:  9/26/23   ·   As:  Director   ·   Accession #:  874015-23-197   ·   File #:  0-19125

Previous ‘4’:  ‘4’ on 7/19/23 for 7/17/23   ·   Next & Latest:  ‘4’ on 12/28/23 for 12/26/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/28/23  Parshall B Lynne                  4          Director    1:5K   Ionis Pharmaceuticals Inc.        Ionis Pharmas Inc.

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of     HTML      5K 
                Securities by an Insider -- edgardoc.xml/5.8                     




        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
SEC Info rendering:  Statement of Changes in Beneficial Ownership of Securities by an Insider
 

The SEC has not released XSLT Stylesheets needed to render this File’s XML Data as a Form.

This is our “Plain Text” rendering:
 
                                                                                                                                                                                
Ownership Document
 
Schema Version:  X0508
Document Type:  4
Period of Report:  9/26/23
Not Subject to Section 16:  0
Issuer:
Issuer CIK:  874015
Issuer Name:  IONIS PHARMACEUTICALS INC
Issuer Trading Symbol:  IONS
Reporting Owner:
Reporting Owner ID:
Owner CIK:  1073385
Owner Name:  PARSHALL B LYNNE
Reporting Owner Address:
Owner Street 1:  2855 GAZELLE COURT
Owner Street 2:
Owner City:  CARLSBAD
Owner State:  CA
Owner ZIP Code:  92010
Owner State Description:
Reporting Owner Relationship:
Is Director?  Yes
Is Officer?  No
Is Ten Percent Owner?  No
Is Other?  No
Aff 10b5 One:  1
Non-Derivative Table:
Non-Derivative Transaction:
Security Title:
Value:  Common Stock
Transaction Date:
Value:  9/26/23
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  S
Equity Swap Involved?  No
Transaction Amounts:
Transaction Shares:
Value:  10,000
Footnote ID:  F1
Transaction Price Per Share:
Value:  45.1268
Footnote ID:  F2
Transaction Acquired-Disposed Code:
Value:  D
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  82,588
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Footnotes:
Footnote - F1Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 16, 2022
Footnote - F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.05 to $45.25, inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc., any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4
Owner Signature:
Signature Name:  By: Patrick R. O'Neil, attorney-in-fact For: B. Lynne Parshall
Signature Date:  9/28/23


Top
Filing Submission 0000874015-23-000197   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 13, 4:42:21.3pm ET